These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23015686)

  • 41. Correlation between fine motor activity and striatal dopamine D2 receptor density in patients with schizophrenia and healthy controls.
    Yang YK; Chiu NT; Chen CC; Chen M; Yeh TL; Lee IH
    Psychiatry Res; 2003 Jul; 123(3):191-7. PubMed ID: 12928107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effort-Based Reinforcement Processing and Functional Connectivity Underlying Amotivation in Medicated Patients with Depression and Schizophrenia.
    Park IH; Lee BC; Kim JJ; Kim JI; Koo MS
    J Neurosci; 2017 Apr; 37(16):4370-4380. PubMed ID: 28283562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Motivational deficits in individuals at-risk for psychosis and across the course of schizophrenia.
    Schlosser DA; Fisher M; Gard D; Fulford D; Loewy RL; Vinogradov S
    Schizophr Res; 2014 Sep; 158(1-3):52-7. PubMed ID: 25008792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New Concepts in Dopamine D
    Urs NM; Peterson SM; Caron MG
    Biol Psychiatry; 2017 Jan; 81(1):78-85. PubMed ID: 27832841
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia.
    Hirvonen J; van Erp TG; Huttunen J; Någren K; Huttunen M; Aalto S; Lönnqvist J; Kaprio J; Cannon TD; Hietala J
    Psychiatry Res; 2006 Jan; 146(1):13-20. PubMed ID: 16361088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Striatal dopamine, reward, and decision making in schizophrenia.
    Deserno L; Schlagenhauf F; Heinz A
    Dialogues Clin Neurosci; 2016 Mar; 18(1):77-89. PubMed ID: 27069382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex.
    Li YC; Kellendonk C; Simpson EH; Kandel ER; Gao WJ
    Proc Natl Acad Sci U S A; 2011 Jul; 108(29):12107-12. PubMed ID: 21730148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patients.
    Esslinger C; Englisch S; Inta D; Rausch F; Schirmbeck F; Mier D; Kirsch P; Meyer-Lindenberg A; Zink M
    Schizophr Res; 2012 Sep; 140(1-3):114-21. PubMed ID: 22784688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence.
    Schmidt K; Nolte-Zenker B; Patzer J; Bauer M; Schmidt LG; Heinz A
    Pharmacopsychiatry; 2001 Mar; 34(2):66-72. PubMed ID: 11302566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is avolition in schizophrenia associated with a deficit of dorsal caudate activity? A functional magnetic resonance imaging study during reward anticipation and feedback.
    Mucci A; Dima D; Soricelli A; Volpe U; Bucci P; Frangou S; Prinster A; Salvatore M; Galderisi S; Maj M
    Psychol Med; 2015 Jun; 45(8):1765-78. PubMed ID: 25577954
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Negative and depressive symptoms differentially relate to real-world anticipatory and consummatory pleasure in schizophrenia.
    Merchant JT; Moran EK; Barch DM
    Schizophr Res; 2022 Mar; 241():72-77. PubMed ID: 35091389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impaired effort allocation in patients with schizophrenia.
    Treadway MT; Peterman JS; Zald DH; Park S
    Schizophr Res; 2015 Feb; 161(2-3):382-5. PubMed ID: 25487699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pavlovian reward prediction and receipt in schizophrenia: relationship to anhedonia.
    Dowd EC; Barch DM
    PLoS One; 2012; 7(5):e35622. PubMed ID: 22574121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreasing Striatopallidal Pathway Function Enhances Motivation by Energizing the Initiation of Goal-Directed Action.
    Carvalho Poyraz F; Holzner E; Bailey MR; Meszaros J; Kenney L; Kheirbek MA; Balsam PD; Kellendonk C
    J Neurosci; 2016 Jun; 36(22):5988-6001. PubMed ID: 27251620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deconstructing Avolition: Initiation vs persistence of reward-directed effort.
    DeRosse P; Barber AD; Fales CL; Malhotra AK
    Psychiatry Res; 2019 Mar; 273():647-652. PubMed ID: 31207847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting the future in schizophrenia: The discrepancy between anticipatory and consummatory pleasure.
    Edwards CJ; Cella M; Tarrier N; Wykes T
    Psychiatry Res; 2015 Sep; 229(1-2):462-9. PubMed ID: 26233824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Compromised Dopaminergic Encoding of Reward Accompanying Suppressed Willingness to Overcome High Effort Costs Is a Prominent Prodromal Characteristic of the Q175 Mouse Model of Huntington's Disease.
    Covey DP; Dantrassy HM; Zlebnik NE; Gildish I; Cheer JF
    J Neurosci; 2016 May; 36(18):4993-5002. PubMed ID: 27147652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modeling excess striatal D2 receptors in mice.
    Kellendonk C
    Prog Brain Res; 2009; 179():59-65. PubMed ID: 20302818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dysfunction of ventral striatal reward prediction in schizophrenia.
    Juckel G; Schlagenhauf F; Koslowski M; Wüstenberg T; Villringer A; Knutson B; Wrase J; Heinz A
    Neuroimage; 2006 Jan; 29(2):409-16. PubMed ID: 16139525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Behavioral phenotypes for negative symptoms in animal models of schizophrenia.
    Miyamoto Y; Nitta A
    J Pharmacol Sci; 2014; 126(4):310-20. PubMed ID: 25409784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.